Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Back

Showing results (61-70 of 745) with videos related to

Pageof 75
Sort By:
Journal of Steroid Biochemistry|May 1, 1986
Inhibition of estrogen 2-hydroxylaseH S Purba, D J Back, A M Breckenridge
British Journal of Clinical Pharmacology|September 1, 1989
Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomesJ F Tjia, D J Back, A M Breckenridge
The British Journal of Dermatology|February 1, 1992
Azoles, allylamines and drug metabolismD J Back, J F Tjia, S M Abel
Contraception|June 1, 1985
Norethisterone concentration in breast milk and infant and maternal plasma during ethynodiol diacetate administrationI D Cooke, D J Back, N E Shroff
Contraception|April 1, 1991
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrelM Orme, D J Back, S Ward, et al.
Arzneimittel-Forschung|September 1, 1992
Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulationsW Kuhnz, B Schütt, J Power, et al.
British Journal of Clinical Pharmacology|March 10, 1998
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesV A Eagling, J F Tjia, D J Back
British Journal of Clinical Pharmacology|July 1, 1988
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolinesD J Back, J F Tjia, J Karbwang, et al.
British Journal of Clinical Pharmacology|March 1, 1992
Metabolism of 2',3'-dideoxyinosine (ddI) in human bloodD J Back, S Ormesher, J F Tjia, et al.
AIDS (London, England)|January 10, 2015
Antiretroviral drugs for prevention of mother-to-child transmission: pharmacologic considerations for a public health approachMohammed Lamorde, Jonathan M Schapiro, David Burger, et al.
Pageof 75

Showing results (61-70 of 745) with videos related to

Sort By:
Pageof 75
Journal of Steroid Biochemistry|May 1, 1986
Inhibition of estrogen 2-hydroxylaseH S Purba, D J Back, A M Breckenridge
British Journal of Clinical Pharmacology|September 1, 1989
Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomesJ F Tjia, D J Back, A M Breckenridge
The British Journal of Dermatology|February 1, 1992
Azoles, allylamines and drug metabolismD J Back, J F Tjia, S M Abel
Contraception|June 1, 1985
Norethisterone concentration in breast milk and infant and maternal plasma during ethynodiol diacetate administrationI D Cooke, D J Back, N E Shroff
Contraception|April 1, 1991
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrelM Orme, D J Back, S Ward, et al.
Arzneimittel-Forschung|September 1, 1992
Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulationsW Kuhnz, B Schütt, J Power, et al.
British Journal of Clinical Pharmacology|March 10, 1998
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesV A Eagling, J F Tjia, D J Back
British Journal of Clinical Pharmacology|July 1, 1988
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolinesD J Back, J F Tjia, J Karbwang, et al.
British Journal of Clinical Pharmacology|March 1, 1992
Metabolism of 2',3'-dideoxyinosine (ddI) in human bloodD J Back, S Ormesher, J F Tjia, et al.
AIDS (London, England)|January 10, 2015
Antiretroviral drugs for prevention of mother-to-child transmission: pharmacologic considerations for a public health approachMohammed Lamorde, Jonathan M Schapiro, David Burger, et al.
Pageof 75